Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
May 24, 2023
What’s new in breast cancer research? SABCS 2022 delivers plenty
Studies highlight research on treatment toxicity, disparities in insurance, gaps in metastatic care, new therapies and more
Could a 100-year-old TB vaccine help scientists find a better one?
Harmless vaccine BCG is made of living bacteria; in tests might serve as a proxy for deadly tuberculosis
Fred Hutchinson Cancer Center receives $710.5 million gift to accelerate cancer and infectious disease research
The landmark gift from the Bezos family will fund multiple scientific priorities, including clinical trials support, new translational research capabilities and recruitment
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
Access to Prostate Cancer Clinical Trials: A County-Level Analysis
From the Bansal Group, Public Health Sciences Division
IAVI and Moderna launch trial of HIV vaccine antigens delivered through mRNA technology
Phase 1 trial aims to build on response seen in proof-of-concept trial
Increasing BIPOC inclusion in clinical trials
From the COVID-19 Prevention Network, Vaccine and Infectious Disease Division
Cancer clinical trials exclude too many patients: That’s changing
Calls for equity, inclusion and better access boost pre-pandemic efforts to open up eligibility, streamline trials
Tip Sheet: Disparities in cancer outcomes, catching up on cancer screenings, boosting immunotherapy effectiveness and SARS-CoV-2 origins
Summaries of recent Fred Hutch research findings and other news
The COVID-19 pandemic and new clinical trial activations
From the The Unger Group, Division of Public Health Sciences